Author:
Lai Ping,Xue Jin-Hua,Xie Mu-Jin,Ye Jin-Hua,Tian Ke-Jun,Ling Jia-Yuan,Zhong Wen-Ting,Chen Dong,Zhong Yi-Ming,Liao Yong-Ling
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference29 articles.
1. 2016 ACC/AHA/HFSA Focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of Cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America;Yancy;Circulation,2016
2. Sacubitril/Valsartan (LCZ696) in heart failure;Khder;Handb Exp Pharmacol,2017
3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014
4. Sacubitril/valsartan: beyond natriuretic peptides;Singh;Heart,2017
5. Sacubitril/valsartan: a novel angiotensin receptor-neprilysin inhibitor;Dargad;Indian Heart J,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献